Aegerion Pharmaceuticals (AEGR) Drop Sharply on Q1 Loss

Aegerion Pharmaceuticals, Inc.

shares fell 18.6% percent to $1.88. Aegerion Pharma reported a Q1 loss of $2.22 per share on sales of $35.7 million. The company also lowered its FY16 sales outlook. Share volume was 819,000, compared to an all-day average of 657,000